Menu Back toSession 5 Track 3: Novel and Emerging Technologies

Medical Affairs and Scientific Communications Forum

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Session 5 Track 3: Novel and Emerging Technologies

Session Chair(s)

Paul  Minne, PharmD, RPh

Paul Minne, PharmD, RPh

  • Director, MSL Team
  • Neurocrine Biosciences, United States
Kay  Uttech, PharmD, MA, RPh

Kay Uttech, PharmD, MA, RPh

  • VP, Strategic Initiatives
  • Indegene, United States
This session will incorporate real life cases and panel discussions showing how technology can turn a problem into a solution. We will highlight uses of new technologies and discuss ways to potentially incorporate them into producing results for Medical Affairs teams. Emerging technology applications into medical affairs best practices and implications for organizations change will be the center of the dialogue.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Interpret digital literacy to compare and contrast the impact that technology has on Medical Affairs
  • Apply technology solutions to common issues and landscape changes occurring in industry
  • Assess the potential future benefits of virtual reality, artificial intelligence, and machine learning and their implications for Medical Affairs


Chris  Wasden, EdD, MBA

What Problem are we Solving?

Chris Wasden, EdD, MBA

  • Head of Pharma Specialty Solutions and Corporate Strategy
  • Happify Health, United States
Colin  Baughman, MBA

Tools to Change Medical Affairs

Colin Baughman, MBA

  • Managing Partner and Founder
  • True North Solutions Inc., United States
Christy  Cheung, PharmD, RPh

Field Medical Perspectives

Christy Cheung, PharmD, RPh

  • Lead, Digital Innovation & Transformation
  • Sanofi, Canada